CIK 0000944809
- Accelerated filer
OPKO HEALTH, INC.
Sign in to watch- Ticker
- OPK
- Exchange
- Nasdaq
- Industry
- Pharmaceutical Preparations
- FY end
- Dec 31
- Incorporated
- DE
- Entity type
- Operating
- EIN
- 752402409
- Phone
- +1 305-575-4181
- Business address
- 4400 BISCAYNE BLVD., MIAMI, FL, 33137
- Former names
- EXEGENICS INC, eXegenics Inc, CYTOCLONAL PHARMACEUTICS INC /DE
- 4 Open-market buy CEO & Chairman bought 100,000 shares at an average $1.76 ($175,804)
- 4 Open-market buy CEO & Chairman bought 75,000 shares at an average $1.75 ($131,260)
- 4 Open-market buy CEO & Chairman bought 100,000 shares at an average $1.82 ($181,752)
- 4 Open-market buy CEO & Chairman bought 650,000 shares at an average $1.84 ($1,194,998)
- 4 Derivatives Options or other derivatives
- 4 Derivatives Options or other derivatives
- 4 Derivatives Options or other derivatives
- 4 Derivatives Options or other derivatives
- 4 Derivatives Options or other derivatives
- 4 Derivatives Options or other derivatives
- 4 Derivatives Options or other derivatives
- 4 Derivatives Options or other derivatives
- 4 Derivatives Options or other derivatives
- 4 Derivatives Options or other derivatives
- 4 Derivatives Options or other derivatives
- 4 Derivatives Options or other derivatives
- 4 Derivatives Options or other derivatives
- 4 Open-market buy Chief Innovation Officer bought 460,245 shares at an average $1.83 ($840,899)
- 4 Grant or award 10% owner acquired 23,148,148 shares (grant or award)
- 4 Open-market buy CEO & Chairman bought 200,000 shares at an average $1.32 ($264,294)
Page 6 of 106 · 2,118 filings